BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 11015011)

  • 1. Do erythrocyte sedimentation rate and C-reactive protein levels have diagnostic usefulness in patients with renal failure?
    Arik N; Bedir A; Günaydin M; Adam B; Halefi I
    Nephron; 2000 Oct; 86(2):224. PubMed ID: 11015011
    [No Abstract]   [Full Text] [Related]  

  • 2. The erythrocyte sedimentation rate, C-reactive protein, plasma fibrinogen and viscosity in chronic renal disease patients with infection.
    Ishak R; Hassan K
    Malays J Pathol; 1989 Aug; 11():29-31. PubMed ID: 2632997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does decreased mean platelet volume predict inflammation in chronic renal failure, dialysis, and transplanted patients?
    Bilen Y; Cankaya E; Keles M; Gulcan E; Uyanik A; Turkeli M; Albayrak B; Yildirim R
    Ren Fail; 2014 Feb; 36(1):69-72. PubMed ID: 24028675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kynurenine, quinolinic acid--the new factors linked to carotid atherosclerosis in patients with end-stage renal disease.
    Pawlak K; Brzosko S; Mysliwiec M; Pawlak D
    Atherosclerosis; 2009 Jun; 204(2):561-6. PubMed ID: 19027117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequency and causes of C-reactive protein and erythrocyte sedimentation rate disagreements in adults.
    Sbong S; Feldman M
    Int J Rheum Dis; 2015 Jan; 18(1):29-32. PubMed ID: 25594234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors influencing erythrocyte sedimentation in patients with chronic renal failure.
    Shusterman N; Kimmel PL; Kiechle FL; Williams S; Morrison G; Singer I
    Arch Intern Med; 1985 Oct; 145(10):1796-9. PubMed ID: 4037939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Inflammation markers in daily practice].
    Le Roy F; Barbier S; Passos EM; Godin M
    Nephrologie; 2003; 24(7):347-50. PubMed ID: 14650745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of high-sensitive C-reactive protein and dialysis adequacy with uremic pruritus.
    Malekmakan L; Malekmakan A; Sayadi M; Pakfetrat M; Sepaskhah M; Roozbeh J
    Saudi J Kidney Dis Transpl; 2015 Sep; 26(5):890-5. PubMed ID: 26354559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential diagnosis of bacterial infection and inflammatory response in kidney diseases using procalcitonin.
    Sitter T; Schmidt M; Schneider S; Schiffl H
    J Nephrol; 2002; 15(3):297-301. PubMed ID: 12113602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Manifestations of oxidant stress in uremia.
    Himmelfarb J; McMonagle E
    Blood Purif; 2001; 19(2):200-5. PubMed ID: 11150810
    [No Abstract]   [Full Text] [Related]  

  • 11. Microinflammation versus inflammation in chronic renal failure patients.
    Tsirpanlis G; Chatzipanagiotou S; Nicolaou C
    Kidney Int; 2004 Nov; 66(5):2093-4. PubMed ID: 15496193
    [No Abstract]   [Full Text] [Related]  

  • 12. [Anemia in patients with chronic kidney failure undergoing systematic hemodialysis treatment].
    Landar' VA; Sarycheva TG; Shemetov VD; Kozinets GI
    Urol Nefrol (Mosk); 1989; (1):54-5. PubMed ID: 2718284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absence of anemia in maintenance hemodialysis.
    Charles G; Lundin AP; Delano BG; Brown C; Friedman EA
    Int J Artif Organs; 1981 Nov; 4(6):277-9. PubMed ID: 7333685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Morphofunctional characteristics of erythrocytes in extracorporeal efferent detoxication].
    Samoĭlov MV; Mishnev OD; Kudriavtsev IuV; Naumov AG; Danilkov AP
    Klin Lab Diagn; 2002 Aug; (8):19-23. PubMed ID: 12362634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparative characteristics of hemostasis system in patients with endstage renal disease admitted for urgent and elective hemodialysis].
    Kotliarova GV; Kozlovskaia NL; Lashutin SV; Komiagin IuV; Shakhnova EA; Dobromyslov IA; Shilov EM; Nesterova SG
    Ter Arkh; 2011; 83(6):36-41. PubMed ID: 21786574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Studies on guanidine compounds in uremia: reevaluation of serum GSA in relation to acute symptoms of uremia (author's transl)].
    Tofuku Y; Kuroda M; Kita T; Takeda R
    Nihon Jinzo Gakkai Shi; 1980 Mar; 22(3):249-58. PubMed ID: 7382166
    [No Abstract]   [Full Text] [Related]  

  • 17. The anemia of renal failure: the role of the hexose monophosphate shunt.
    Tet-Ken-Voo R
    Can J Med Technol; 1973 Oct; 35(5):14 passim. PubMed ID: 4756807
    [No Abstract]   [Full Text] [Related]  

  • 18. Secondary hyperoxalemia in chronic renal failure.
    Balcke P; Schmidt P; Zazgornik J; Kopsa H; Deutsch E
    Int J Artif Organs; 1982 May; 5(3):141-3. PubMed ID: 7107047
    [No Abstract]   [Full Text] [Related]  

  • 19. [Changes in lipid metabolism in uremia].
    Ianhez LE; Cruz O; Sabbaga E
    Rev Hosp Clin Fac Med Sao Paulo; 1976 Oct; 31(5):386-91. PubMed ID: 981882
    [No Abstract]   [Full Text] [Related]  

  • 20. Carbamylated plasma protein in renal failure.
    Oimomi M; Nishimoto S; Matsumoto S; Hatanaka H; Ishikawa K; Kawasaki T; Yoshimura Y; Baba S
    Nihon Jinzo Gakkai Shi; 1986 Mar; 28(3):269-71. PubMed ID: 3723861
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.